HOME CANCER GLOSSARY  CANCER PHOTOS  NEW CANCER BOOKS  LINKING  ADVERTISE

   
 

Free Financial Help for Cancer Patients
Gov't regulated program

Breast Cancer "Switch" Found

Cancer Pictures

Best Natl Cancer Ctrs

Cancer Centers
by State


Cancer Societies

Newest Treatments
by cancer type

MyCancerNews.com

Cancer Newsletters

Medical Journals

Cancer Calculator

Nat'l Cancer Inst.

MedLine Cancer

Chemotherapy

Other helpful links

Additional Help
for Cancer Patients

More Cancer Photos

Breast Cancer Current Topics in Breast Cancer


A drug that prevents osteoporosis may cut a woman's risk of breast cancer in half


The initial results of a study comparing the drugs tamoxifen, a drug taken to prevent breast cancer, and raloxifene, a drug used to treat and prevent osteoporosis, has shown that both work equally well in reducing a woman's risk of breast cancer. In a study conducted by the National Cancer Institute, which included almost 20,000 women at an average age of 58, researchers found that both tamoxifen and raloxifene cut a woman's risk of breast cancer in half. However, tamoxifen has been linked to serious side effects, raising the risk of life-threatening blood clots and uterine cancer. On the other hand, the researchers discovered that the women taking raloxifene had 36 percent fewer uterine cancers and 29 percent fewer blood clots. Since many women at high risk for breast cancer refuse to take tamoxifen because of the side effects, raloxifene seems to be a safer choice. "Although no drugs are without side effects, tamoxifen and raloxifene are vital options for women who are at increased risk of breast cancer and want to take action, said Dr. Leslie Ford, associate director for clinical research at the NCI's Division of Cancer Prevention. "For many women, raloxifene's benefits will outweigh its risks in a way that tamoxifen's benefits do not.




 

Alternative Therapies

Melanoma Skin Cancer

Complementary and Alternative Cancer
Care Guidelines

Cancer Treatment Research Library

Dangerous Doctors
...is yours safe?

Cancer Archives

 

 

MEMBERSHIPS:     

About us
Privacy policy
Conditions of use

 


Nat'l Cervical
Cancer Coalition

logo nbtf
National Brain
Tumor
Foundation


Nat'l Ovarian
Cancer Coalition


Breast Cancer
Research

MCN
My
Cancer News

 

Special
Thanks
 TECH SUPPORT

Codebrain
Codebelly


NOTICE:  No information on this CANCER research site is provided, intended or implied to substitute for trained, professional medical advice, CANCER diagnosis or CANCER treatmentAs a condition of use of this cancer website, all visitors agree to seek trained medical advice before using any cancer treatment or cancer information found on this website and agree discuss these with their physicians prior to use and to hold RobertsReview and all entities affiliated with, contributing to, and/or operating this cancer research website harmless in regard to all information provided herein and/or from any decisions that may flow from use of this information.  RobertsReview in no way recommends, endorses or verifies the accuracy or claims of any of the cancer information provided herein by "third parties" regardless of their affiliation.

©1997-2006 RobertsReview, Wickford, RI USA. No information contained on this website may be reproduced in any form in any media.  Single copies may be reprinted for non-commercial use.